📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial. (2018)

First Author: Thwaites GE

Attributed to: Other infectious diseases of global public health significance funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s0140-6736(17)32456-x

PubMed Identifier: 29249276

Publication URI: http://europepmc.org/abstract/MED/29249276

Type: Journal Article/Review

Volume: 391

Parent Publication: Lancet (London, England)

Issue: 10121

ISSN: 0140-6736